207
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Neuroprotection of paclitaxel against cerebral ischemia/reperfusion-induced brain injury through JNK3 signaling pathway

, , , , , & show all
Pages 402-407 | Received 17 Aug 2011, Accepted 03 Sep 2011, Published online: 07 Nov 2011
 

Abstract

In this study, we investigated the neuroprotective effects of paclitaxel in transient cerebral ischemia and possible regulatory mechanism of these neuroprotection. Our data showed that paclitaxel can down-regulate the increased MLK3, JNK3, c-Jun, Bcl-2, and caspase-3 phosphorylation induced by ischemia injury. Cresyl violet staining and immunohistochemistry results demonstrated that paclitaxel had neuroprotective effect against ischemia/reperfusion-induced neuronal cell death. These results indicated that paclitaxel has neuroprotection in ischemic injury through JNK3 signaling pathway and provided a novel possible drug in therapeutics of brain ischemia.

Acknowledgments

The authors wish to thank Yuan’s laboratory (Department of Chemistry, Yunnan Normal University) for offering paclitaxel.

Declaration of interest

This work is supported by the National Natural Science Foundation of China Grant (No. 81171075), Natural Science Foundation of the Jiangsu Higher Education Institutions of China (No. 08KJB180010, 11KJB310012, 09KJA180006), Foundation of Xuzhou Medical College (No. 2010KJZ13), and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institution.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.